chr2-105272937-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_004257.6(TGFBRAP1):c.1890G>A(p.Lys630=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00237 in 1,611,686 control chromosomes in the GnomAD database, including 101 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 60 hom., cov: 31)
Exomes 𝑓: 0.0013 ( 41 hom. )
Consequence
TGFBRAP1
NM_004257.6 synonymous
NM_004257.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0100
Genes affected
TGFBRAP1 (HGNC:16836): (transforming growth factor beta receptor associated protein 1) This gene encodes a protein that binds to transforming growth factor-beta (TGF-beta) receptors and plays a role in TGF-beta signaling. The encoded protein acts as a chaprone in signaling downstream of TGF-beta. It is involved in signal-dependent association with SMAD4. The protein is also a component of mammalian CORVET, a multisubunit tethering protein complex that is involved in fusion of early endosomes. [provided by RefSeq, Jun 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 2-105272937-C-T is Benign according to our data. Variant chr2-105272937-C-T is described in ClinVar as [Benign]. Clinvar id is 786864.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.01 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0126 (1912/151466) while in subpopulation AFR AF= 0.0444 (1833/41272). AF 95% confidence interval is 0.0427. There are 60 homozygotes in gnomad4. There are 886 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1912 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TGFBRAP1 | NM_004257.6 | c.1890G>A | p.Lys630= | synonymous_variant | 10/12 | ENST00000393359.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TGFBRAP1 | ENST00000393359.7 | c.1890G>A | p.Lys630= | synonymous_variant | 10/12 | 1 | NM_004257.6 | P1 | |
TGFBRAP1 | ENST00000595531.5 | c.1890G>A | p.Lys630= | synonymous_variant | 9/11 | 1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0126 AC: 1912AN: 151346Hom.: 61 Cov.: 31
GnomAD3 genomes
AF:
AC:
1912
AN:
151346
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00347 AC: 869AN: 250706Hom.: 22 AF XY: 0.00257 AC XY: 349AN XY: 135562
GnomAD3 exomes
AF:
AC:
869
AN:
250706
Hom.:
AF XY:
AC XY:
349
AN XY:
135562
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00130 AC: 1903AN: 1460220Hom.: 41 Cov.: 32 AF XY: 0.00113 AC XY: 823AN XY: 726476
GnomAD4 exome
AF:
AC:
1903
AN:
1460220
Hom.:
Cov.:
32
AF XY:
AC XY:
823
AN XY:
726476
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0126 AC: 1912AN: 151466Hom.: 60 Cov.: 31 AF XY: 0.0120 AC XY: 886AN XY: 74040
GnomAD4 genome
AF:
AC:
1912
AN:
151466
Hom.:
Cov.:
31
AF XY:
AC XY:
886
AN XY:
74040
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 13, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at